ACE2 and COVID-19: The high transmissivity of COVID-19 can be explained by the high viral load in the viremia phase, and an effective molecular mechanism that recognizes the binding protein angiotensin-converting enzyme 2 (ACE2), which allows infecting human alveolar epithelial cells [3,4].